<DOC>
	<DOCNO>NCT00891852</DOCNO>
	<brief_summary>The overall significance study develop laboratory develop test ( LDT ) use new marker maternal blood well identify pregnancy child chromosome abnormality Down syndrome ( trisomy 21 ) , Edward 's syndrome ( trisomy 18 ) , Patau syndrome ( trisomy 13 ) , Klinefelter syndrome , ( 47 , XXY ) , chromosome abnormality . Accomplishing task would reduce need invasive amniocentesis CVS procedure .</brief_summary>
	<brief_title>Non-Invasive Determination Fetal Chromosome Abnormalities</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Trisomy</mesh_term>
	<mesh_term>Klinefelter Syndrome</mesh_term>
	<mesh_term>Chromosome Aberrations</mesh_term>
	<mesh_term>Chromosome Disorders</mesh_term>
	<criteria>This study applicable woman 8 30 week ' gestation determine increase risk fetal aneuploidy . In interest expedite simplify study , investigator want woman already decide undergo secondtrimester amniocentesis CVS . The exclusion criterion mention .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>